Loading...
XTAE
ELRN
Market cap50mUSD
Oct 07, Last price  
288.00ILS
1D
-5.64%
1Q
-25.68%
Jan 2017
-83.89%
Name

Elron Ventures Ltd

Chart & performance

D1W1MN
XTAE:ELRN chart
P/E
5.00
P/S
—
EPS
0.19
Div yield, %
30.11%
Shrs. gr., 5y
4.43%
Rev. gr., 5y
0.10%
Revenues
0
-100.00%
12,863,0004,371,0007,020,00041,706,0009,608,00014,103,000097,000374,000889,00000004,314,00037,822,00089,514,00016,085,00043,847,0000
Net income
10m
-55.38%
3,032,000-37,095,000-71,834,000-14,304,00066,333,000-8,417,0004,357,00017,935,00085,494,0002,451,000-26,814,000-25,482,000-15,792,000-22,376,000-17,723,0005,484,00069,524,000-8,174,00022,577,00010,073,472
CFO
-2m
L-45.43%
-11,853,000-26,898,000-47,345,000-46,008,000-35,664,000-26,664,000-15,900,000-10,695,000-10,150,000-20,648,000-15,810,000-17,656,000-18,598,000-14,067,000-11,129,000-5,194,000-5,533,000-3,538,000-3,861,000-2,107,000
Dividend
Aug 25, 202532.03951 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Elron Ventures Ltd. is a holding company, which engages in the investment in early-stage technology companies such as enterprise software, cybersecurity, and healthcare industries. Its portfolio includes Cybersixgill, Open Legacy, Scribe, Keepy, and Notal Vision. The Company was founded by Uzia Galil on October 20, 1961 and is headquartered in Tel Aviv, Israel.

Key people

Dan Hoz
Chairman of the Board
Chief Executive Officer · since 2010
Niv Levy
Finance Director · since 2011
Yaron Elad
Vice President - Finance · since 2010
Zohar Rozenberg
Vice President · since 2016
Internal Auditor · since 2004
Director · since 2007
Director · since 2019
Gerardo Tyszberowicz
Director · since 2017
Vice Chairman of the Board & Director · since 2016
Yehuda Freidenberg
External Director · since 2014
Lee-Bath Nelson
External Director · since 2014
External Director · since 2012
IPO date
Jan 01, 1975
Employees
11
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT